Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
BHV-1400 Targets the non-immunosuppressive, selective depletion of circulating galactose-deficient Iga1 in Iga nephropathy, Biohaven Pharmaceuticals, Inc , Poster at the 4th Annual Targeted Protein Degradation Summit Europe, London, United Kingdom, March 19-21, 2024 (2024)
doi:10.1371/journal.pbio.1001603
Each row states what was actually used, in what species, by what route, with the citation and each row that has no evidence says so
5-Amino-1MQ inhibits nicotinamide N-methyltransferase (NNMT), restoring NAD+ pools depleted in metabolic dysfunction and improving mitochondrial oxidative capacity by 6080% in preclinical models
US$ 23.78
US$ 20.69
US$ 25.08
US$ 22.83
US$ 21.75
US$ 25.87
